Yardley, PA, July 17, 2007, Axendia, Inc. a trusted advisor to Life-Science Executives on Business, Regulatory and Technology strategies, today announced that it has been selected by Drexel University’s School of Biomedical Engineering, Science and Health Systems (Drexel University) to provide advisory services on Technology Commercialization.
Drexel University has received the Translational Research Partnership Award in Biomedical Engineering from the Coulter Foundation, a private, nonprofit foundation dedicated to supporting biomedical engineering translational research that addresses unmet health care needs.
“Our goal is to promote and develop translational research activities to increase effective collaborations between biomedical engineers and clinicians, increase the conversion of promising technologies into commercialized products and clinical applications” commented Dr. Robert Loring, Drexel University’s Senior Entrepreneur in Residence. “Axendia’s 50 plus years of combined Life-Science experience will enhance Drexel’s strong Biomedical Technology Transfer and Commercialization efforts” added Dr. Loring.
“There are significant healthcare benefits in bringing promising technologies into commercialized products and clinical applications by enabling the collaboration between leading Biomedical Academic Institutions, and the private sector”, commented Daniel R. Matlis, founder and President of Axendia. “We are very pleased to have been selected by Drexel University’s Biomedical Department to provide advisory services on this important initiative.” Matlis added.
About Drexel School of Biomedical Engineering, Science and Health Systems
The Drexel University School of Biomedical Engineering, Science and Health Systems’ technology platforms encompass the translation of multiple clinical or personal health-care applications, from cardiovascular engineering to neurology and from skin bioengineering to pediatric technologies. The School’s strategic academic specializations include biosensing, bioimaging, drug delivery, cellular tissue engineering, neuroengineering and integrated bioinformatics, enabled by bionanotechnologies, biomedical ultrasound and optics and information engineering.
About Axendia
Axendia, Inc. is the leading analysis and strategic advisory firm focused on the Life-Sciences and Healthcare markets. Our Mission is to be the most trusted advisor to Life-Science Executives on Business, Regulatory and Technology issues. With over 50 years experience in the Life-Sciences and Healthcare industries, Axendia provides a unique combination of hands on experience coupled with strategic vision. This enables us to successfully identify, create and execute strategies which provide lasting business value for our clients. Additional information on Axendia’s can be found at www.Axendia.com